pioneer 6 semaglutide Post hoc analysis of SUSTAIN and 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with experience more stable kidney function compared with placebo Frontiers | Cardiovascular Safety and

This is a drug-class mechanism, not a claim specific to any compounded formulation

Abdel-Naeem HH, Ebaid EM, Khalel KH, Imre K, Morar A, Herman V, et al

Patch or ring formulations may also circumvent gastric-emptying-related absorption issues

A 2024 study published in Proceedings of the National Academy of Sciences estimates that GLP-1s can prevent more than 42,000 deaths each year, including 11,000 deaths among people with type 2 diabetes

Key Differences Affecting Dose Conversion While both drugs share similar mechanisms, tirzepatides dual receptor activity leads to differences in potency and side effect profiles